Purpose

The study is a randomized crossover trial. Current smokers will complete a session with each product: usual brand cigarette, e-cigarette, and heat-not-burn. The objective of this survey is to assess for ongoing use of study products and is part of safety monitoring.

Condition

Eligibility

Eligible Ages
Over 21 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Non-Hispanic African American or white/Caucasian, - ≥21 years old, smoke 5-30 cigarettes per day, - daily cigarette smoker - smoked at current rate for at least 6 months - interested in trying e-cigarettes and heat not burn products - not interested in or unable/unwilling to quit cigarette smoking - willing to complete three in-person study visits - willing to have IV catheter placed

Exclusion Criteria

  • Interested in quitting cigarettes in the next 30 days - use of smoking cessation pharmacotherapy in the past 30 days - use of non-cigarette tobacco products in the past 30 days - use of e-cigarettes >5x in lifetime - use of e-cigarettes ≥4 of the past 30 days - use of heat not burn products >5x in lifetime - use of heat not burn products ≥4 of the past 30 days - weight < 110 lbs - uncontrolled hypertension (systolic BP ≥ 180 or diastolic BP ≥ 105) - pregnant, plans to become pregnant, or breastfeeding - live >10 miles from study site (Fairway CRU) - current enrollment is a research study or program that aims to alter tobacco use

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover Assignment
Intervention Model Description
20 eligible African American and white smokers will be randomized. A 1:1 randomization to product order (combustible cigarette, e-cigarette, heat-not-burn vs. combustible cigarette, heat-not-burn, e-cigarette). Randomization will be determined by computer-generated random numbers. Randomization assignments will be placed in sealed envelopes with sequential study identification numbers. After baseline data collection has been completed, the research assistant will select the sequential study identification number to determine the randomization assignment No blinding is involved. Due to the pilot nature of the current study, formal power calculations were not conducted. ANOVAs will be conducted to detect within-subject differences between products. A Bonferroni correction will be applied to adjust for multiple comparisons.
Primary Purpose
Other
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
E-Cigarette then Heat not burn.
We will use a 1:1 fashion randomization to product order (combustible cigarette, e-cigarette, heat-not-burn device.
  • Combination Product: E-cigarette and Heat not burn
    Current smokers will be randomized to session order and complete a standardized 10-puff bout (5 minutes) followed by a 60-minute ad libitum session with each product (usual brand cigarette, e-cigarette, heat-not-burn).
Active Comparator
Heat not burn then E-Cigarette
We will use a 1:1 fashion randomization to product order combustible cigarette, heat-not-burn device, e-cigarette.
  • Combination Product: E-cigarette and Heat not burn
    Current smokers will be randomized to session order and complete a standardized 10-puff bout (5 minutes) followed by a 60-minute ad libitum session with each product (usual brand cigarette, e-cigarette, heat-not-burn).

More Details

Status
Completed
Sponsor
University of Kansas Medical Center

Study Contact

Detailed Description

The study is a randomized crossover trial. Current smokers will be randomized to session order and complete a standardized 10-puff bout (5 minutes) followed by a 60-minute ad libitum session with each product (usual brand cigarette, e-cigarette, heat-not-burn). Throughout each visit, blood will be collected for nicotine analysis via an IV catheter placed in the patient's arm. Blood samples will be aliquoted into two separate vials. One will be analyzed for the current study and one will be placed in a biospecimen repository if participant provides consent for biorepository. Puff topography will be collected passively throughout the session to measure puffing patterns. Participants will complete self-report measures of nicotine withdrawal and craving. Finally, breath samples will be collected to measure changes in exhaled carbon monoxide, a potent lung toxicant, pre- and post-product use. At the final visit, participants will complete a behavioral economics concurrent choice task (see below for description) to behaviorally measure their decisions regarding use of e-cigarettes or heat not burn products in place of cigarettes. Finally, participants will be contacted by phone 6 months following the conclusion of visit 3 (or study discontinuation) to complete a phone survey. The objective of this survey is to assess for ongoing use of study products and is part of safety monitoring. We have no hypotheses related to the follow-up.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.